BR0315939A - Métodos para tratar ou prevenir degeneração macular em um paciente e maculopatia relacionada com idade, neovascularização coroidal, descolamento do epitélio de pigmento ou atrofia de epitélio de pigmento retinal e composição farmacêutica - Google Patents
Métodos para tratar ou prevenir degeneração macular em um paciente e maculopatia relacionada com idade, neovascularização coroidal, descolamento do epitélio de pigmento ou atrofia de epitélio de pigmento retinal e composição farmacêuticaInfo
- Publication number
- BR0315939A BR0315939A BR0315939-6A BR0315939A BR0315939A BR 0315939 A BR0315939 A BR 0315939A BR 0315939 A BR0315939 A BR 0315939A BR 0315939 A BR0315939 A BR 0315939A
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- treating
- preventing
- macular degeneration
- age
- Prior art date
Links
- 208000002780 macular degeneration Diseases 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 4
- 206010064930 age-related macular degeneration Diseases 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 208000005590 Choroidal Neovascularization Diseases 0.000 title 1
- 206010060823 Choroidal neovascularisation Diseases 0.000 title 1
- 208000032436 Retinal depigmentation Diseases 0.000 title 1
- 239000000049 pigment Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 229940118135 JNK inhibitor Drugs 0.000 abstract 1
- 239000012825 JNK inhibitor Substances 0.000 abstract 1
- 206010029113 Neovascularisation Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 230000001605 fetal effect Effects 0.000 abstract 1
- 238000000554 physical therapy Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42289602P | 2002-10-31 | 2002-10-31 | |
| US10/699,105 US20040092568A1 (en) | 2002-10-31 | 2003-10-30 | Methods for the treatment, prevention and management of macular degeneration |
| PCT/US2003/034662 WO2004041191A2 (en) | 2002-10-31 | 2003-10-31 | Methods for the treatment, prevention and management of macular degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0315939A true BR0315939A (pt) | 2005-09-13 |
Family
ID=32233518
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0315939-6A BR0315939A (pt) | 2002-10-31 | 2003-10-31 | Métodos para tratar ou prevenir degeneração macular em um paciente e maculopatia relacionada com idade, neovascularização coroidal, descolamento do epitélio de pigmento ou atrofia de epitélio de pigmento retinal e composição farmacêutica |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20040092568A1 (enExample) |
| EP (1) | EP1565188A2 (enExample) |
| JP (1) | JP2006507307A (enExample) |
| KR (1) | KR20050061596A (enExample) |
| AU (1) | AU2003286802A1 (enExample) |
| BR (1) | BR0315939A (enExample) |
| CA (1) | CA2504028A1 (enExample) |
| MX (1) | MXPA05004550A (enExample) |
| NZ (1) | NZ540187A (enExample) |
| TW (1) | TW200420290A (enExample) |
| WO (1) | WO2004041191A2 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6984652B2 (en) * | 2003-09-05 | 2006-01-10 | Warner-Lambert Company Llc | Gyrase inhibitors |
| US7803824B2 (en) * | 2004-10-29 | 2010-09-28 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases to treat glaucoma |
| US20060094753A1 (en) * | 2004-10-29 | 2006-05-04 | Alcon, Inc. | Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| ES2284308B1 (es) * | 2005-03-08 | 2008-08-01 | Bsh Electrodomesticos España, S.A. | Tambor para maquina lavadora de ropa. |
| CA2663545A1 (en) * | 2006-09-19 | 2008-03-27 | Phylogica Limited | Neuroprotective peptide inhibitors of ap-1 signaling and uses thereof |
| JP5640005B2 (ja) | 2008-07-14 | 2014-12-10 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｄａｃおよび／またはｃｄｋ阻害剤としてのイミダゾシルピリジン化合物 |
| EP2303881A2 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Fused heterocyclyc inhibitors of histone deacetylase and/or cyclin-dependent kinases |
| EP2303841A1 (en) | 2008-07-14 | 2011-04-06 | Gilead Sciences, Inc. | Oxindolyl inhibitor compounds |
| KR20110038159A (ko) | 2008-07-28 | 2011-04-13 | 길리애드 사이언시즈, 인코포레이티드 | 사이클로알킬리덴 및 헤테로사이클로알킬리덴 히스톤 데아세틸라아제 억제제 화합물 |
| EP2374825A1 (en) | 2008-12-17 | 2011-10-12 | Keio University | Photodynamic therapeutic agent showing accumulation of cell-specific functions |
| EA201171188A1 (ru) * | 2009-03-30 | 2012-05-30 | Сантен Фармасьютикал Ко., Лтд. | Профилактическое или терапевтическое средство против болезни сетчатки и способ профилактики или лечения болезни сетчатки с использованием jnk (c-jun-аминоконцевая киназа)-ингибиторного пептида, а также применение указанного пептида |
| CA2763786C (en) | 2009-06-08 | 2014-09-30 | Gilead Sciences, Inc. | Alkanoylamino benzamide aniline hdac inihibitor compounds |
| ES2463826T3 (es) | 2009-06-08 | 2014-05-29 | Gilead Sciences, Inc. | Compuestos inhibidores de HDAC de cicloalquilcarbamato benzamida anilina |
| CN115784993A (zh) * | 2022-11-23 | 2023-03-14 | 四川大学华西医院 | 一种3-氨基吲唑类化合物的制备及其治疗帕金森病的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5075116A (en) * | 1989-04-20 | 1991-12-24 | Lahaye Laboratories, Inc. | Composition and method for treatment of macular degeneration |
| KR20080028516A (ko) * | 1999-08-19 | 2008-03-31 | 시그널 파머슈티컬스 인크 | Ｊｎｋ억제제로서의 피라졸로안트론과 그 유도체 및 이를함유하는 조성물 |
| US6204270B1 (en) * | 1999-11-12 | 2001-03-20 | Eyal S. Ron | Ophthalmic and mucosal preparations |
| JP4739632B2 (ja) * | 2000-02-05 | 2011-08-03 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｅｒｋのインヒビターとして有用なピラゾール組成物 |
| US6897231B2 (en) * | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| US7129242B2 (en) * | 2000-12-06 | 2006-10-31 | Signal Pharmaceuticals, Llc | Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto |
-
2003
- 2003-10-30 US US10/699,105 patent/US20040092568A1/en not_active Abandoned
- 2003-10-31 NZ NZ540187A patent/NZ540187A/en unknown
- 2003-10-31 BR BR0315939-6A patent/BR0315939A/pt not_active IP Right Cessation
- 2003-10-31 TW TW092130487A patent/TW200420290A/zh unknown
- 2003-10-31 CA CA002504028A patent/CA2504028A1/en not_active Abandoned
- 2003-10-31 JP JP2004550330A patent/JP2006507307A/ja active Pending
- 2003-10-31 EP EP03778016A patent/EP1565188A2/en not_active Withdrawn
- 2003-10-31 MX MXPA05004550A patent/MXPA05004550A/es unknown
- 2003-10-31 WO PCT/US2003/034662 patent/WO2004041191A2/en not_active Ceased
- 2003-10-31 KR KR1020057007658A patent/KR20050061596A/ko not_active Withdrawn
- 2003-10-31 AU AU2003286802A patent/AU2003286802A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ540187A (en) | 2008-03-28 |
| MXPA05004550A (es) | 2005-07-26 |
| AU2003286802A1 (en) | 2004-06-07 |
| WO2004041191A3 (en) | 2004-12-02 |
| EP1565188A2 (en) | 2005-08-24 |
| CA2504028A1 (en) | 2004-05-21 |
| JP2006507307A (ja) | 2006-03-02 |
| KR20050061596A (ko) | 2005-06-22 |
| TW200420290A (en) | 2004-10-16 |
| WO2004041191A2 (en) | 2004-05-21 |
| US20040092568A1 (en) | 2004-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0608152A2 (pt) | formulações para tratamento ocular | |
| BR0317033A (pt) | Vitreólise farmacológica | |
| CA2603902A1 (en) | Ophthalmic formulations and uses thereof | |
| BRPI0415971A (pt) | método para tratar, prevenir ou controlar degeneração macular, e, composição farmacêutica | |
| BR0302584A (pt) | Combinação de brimonidina e timolol para uso oftálmico tópico | |
| CU23208A3 (es) | Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea | |
| BRPI0408690A (pt) | composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto | |
| BRPI0517891A (pt) | composições compreendendo azelastina e métodos de uso das mesmas | |
| BR0315573A (pt) | Método para tratar, prevenir, controlar e/ou modificar dor em um paciente e composição farmacêutica | |
| BG63612B1 (bg) | Състав и метод за профилактика и лечение на нiv идруги инфекциозни заболявания при човека | |
| BRPI0412526A (pt) | composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica | |
| BR0108173A (pt) | Composições farmacêuticas de toxina de botulina | |
| BR9909474A (pt) | Formas ii, cristalina e v de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, solvato de etanol de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, composição, composto, uso de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol, e, processos para o tratamento de uma infecção viral em um humano e para a produção de 5,6-dicloro-2-(isopropilamino)-1-beta-l-ribofuranosil -1h-benzimidazol | |
| Sheshala et al. | Formulation and characterization of pH induced in situ gels containing sulfacetamide sodium for ocular drug delivery: A combination of Carbopol®/HPMC polymer | |
| GEP20094781B (en) | Sulfonamide derivatives for the treatment of diseases | |
| BR0316057A (pt) | Métodos de tratar, controlar ou prevenir um câncer especìfico e uma doença associada com angiogênese indesejada e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo e com a terapia de radiação, terapia hormonal, terapia biológica ou imunoterapia em um paciente sofrendo de um câncer especìfico, composição farmacêutica e kit | |
| WO2006073786A3 (en) | Ophthalmic compositions comprising steroid and cyclosporine for dry eye therapy | |
| DE69227259D1 (de) | Film zur lokalen arzneistoffabgabe für periodontale behandlung | |
| BR0116251A (pt) | composição de lágrimas artificiais contendo uma combinação de três demulcentes | |
| AR032138A1 (es) | Derivados de 6-hidroxi-indazol, una composicion oftalmica, y el uso de dichos derivados para la manufactura de un medicamento para el tratamiento de glaucoma | |
| BRPI0409884A (pt) | compostos, composições farmacêuticas, método para o tratamento ou porfilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
| BRPI0409882A (pt) | compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, usos de compostos e de um ou mais compostos em combinação com outros compostos farmacologicamente ativos | |
| BR0315316A (pt) | Métodos de tratar, prevenir ou controlar uma sìndrome mielodisplásica, e de reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de uma sìndrome mielodisplásica, composição farmacêutica, forma de dosagem unitária, e, kit | |
| BR0115077A (pt) | Métodos e composições para o tratamento de doenças dos olhos | |
| CN108883081A (zh) | 蛋白酶体抑制剂治疗眼部疾病的用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE 6A. E 7A. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2073 DE 28/09/2010. |